75238-29-8

Basic information

• Product Name: METHYL 3,5-DIHYDROXY-4-METHYLBENZOATE
• Synonyms: METHYL 3,5-DIHYDROXY-4-METHYLBENZOATE;3,5-Dihydroxy-p-toluic acid methyl ester (COOCH3=1);3,5-dihydroxy-4-methylbenzoic acid methyl ester
• CAS NO: 75238-29-8
• Molecular Formula: C₉H₁₀O₄
• Molecular Weight: 182.17
• Product Categories: Acids & Esters;Phenols
• Mol File: 75238-29-8.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: METHYL 3,5-DIHYDROXY-4-METHYLBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 3,5-DIHYDROXY-4-METHYLBENZOATE(75238-29-8)
• EPA Substance Registry System: METHYL 3,5-DIHYDROXY-4-METHYLBENZOATE(75238-29-8)

Safety Data

• Hazardous Substances Data: 75238-29-8(Hazardous Substances Data)

Usage

General Description

METHYL 3,5-DIHYDROXY-4-METHYLBENZOATE is a chemical compound with the molecular formula C9H10O4. It is commonly used as a flavoring agent in food and beverages due to its sweet and fruity aroma. This ester compound is also utilized in the production of synthetic flavors and fragrances. Additionally, it has been studied for its potential antioxidant and anti-inflammatory properties. METHYL 3,5-DIHYDROXY-4-METHYLBENZOATE may have applications in the pharmaceutical and cosmetic industries, as well as in the formulation of various consumer products.

Upstream product

• 186581-53-3 diazomethane 
• 28026-96-2 3,5-dihydroxy-4-methylbenzoic acid 
• 67-56-1 methanol 
• 75238-28-7 3,5-disulphonic-4-methyl-benzoic acid 
• 99-94-5 p-Toluic acid 
• 74-88-4 methyl iodide 
• 34696-31-6 methyl 3,5-bis(benzyloxy)-4-methylbenzoate 

Downstream Products

• 60441-79-4 methyl 3,5-dimethoxy-4-methylbenzoate 
• 69660-38-4 5-Hydroxy-3-methoxy-4-methylbenzoesaeure-methylester 
• 72922-62-4 3-hydroxy-5-methoxy-4-methyl-benzoic acid 
• 51333-71-2 methyl 2-formyl-3,5-dihydroxy-4-methylbenzoate 
• 254966-02-4 methyl 3,5-bis(methoxycarbonylbutoxy)-4-methylbenzoate 
• 254966-03-5 methyl 3,5-bis(10-methoxycarbonyldecyloxy)-4-methylbenzoate 
• 254966-01-3 methyl 3,5-bis(methoxycarbonylmethoxy)-4-methylbenzoate 
• 326598-92-9 all-cis-3,5-dihydroxy-4-methyl-1-(methoxycarbonyl)cyclohexane 
• 326598-97-4 cis,cis-3,5-diacetoxy-4-methyl-1-(methoxycarbonyl)cyclohexane 
• 72922-69-1 methyl 3-(benzyloxy)-5-methoxy-4-methylbenzoate 
• 301530-15-4 3-(benzyloxy)-5-methoxy-4-methylbenzaldehyde 
• 301530-16-5 3-benzyloxy-5-methoxy-4-methylstyrene 
• 254966-07-9 methyl 4-formyl-3,5-bis(methoxycarbonylmethoxy)benzoate 
• 254966-04-6 methyl 4-(bromomethyl)-3,5-bis(methoxycarbonylmethoxy)benzoate 

Relevant articles and documents

Preparation of tricyclic analog as CDE ring model of renieramycin marine natural product by novel photo-induced transformation of 6-methoxy-1,2,3,4-tetrahydroisoquinoline-5,8-dione

2-Acetyl-6-[(benzyloxy)methyl]-9-methoxy-8-methyl-11,11adihydro-2H-pyrazino[1,2-b]isoquinoline-1,4,7,10(3H,6H)-tetraone (11a) was prepared as the CDE ring model of renieramycins, and its novel photo-induced transformation was demonstrated to construct a 1,3-dioxol ring.

MODIFIED NUCLEOTIDE REAGENTS

Labeled nucleotide analogs comprising at least one avidin protein, at least one dye-labeled compound, and at least one nucleotide compound are provided. The analogs are useful in various fluorescence-based analytical methods, including the analysis of highly multiplexed optical reactions in large numbers at high densities, such as single molecule real time nucleic acid sequencing reactions. The analogs are detectable with high sensitivity at desirable wavelengths. They contain structural components that modulate the interactions of the analogs with DNA polymerase, thus decreasing photodamage and improving the kinetic and other properties of the analogs in sequencing reactions. Also provided are nucleotide and dye-labeled compounds of the subject analogs, as well as intermediates useful in the preparation of the compounds and analogs. Compositions comprising the compounds, methods of synthesis of the intermediates, compounds, and analogs, and mutant DNA polymerases are also provided.

New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa

The present invention relates to compounds comprising the following formula: R0—Q—X—Q′—W—U—V—G—M??(I) These compounds are useful as pharmacologically active compounds. They exhibit an antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders such as thromboembolic diseases or restenoses. These compounds are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can generally be used to treat, prevent, or cure conditions in which an undesired activity of factor Xa and/or factor VIIa is present, or where inhibition of factor Xa and/or factor VIIa is intended. The invention further relates to processes for the preparation of these compounds, methods of their use (e.g., as active ingredients in pharmaceuticals), and pharmaceutical preparations comprising them.